Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice

被引:42
作者
Del Campo, Judith [2 ]
Lindqvist, Madelene [1 ]
Cuello, Maribel [2 ]
Backstrom, Malin [3 ]
Cabrerra, Osmir [2 ]
Persson, Josefine [1 ]
Perez, Oliver [2 ]
Harandi, Ali M. [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden
[2] Finlay Inst, Dept Immunol, Havana, Cuba
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol,Mammalian Prot Expre, Gothenburg, Sweden
基金
瑞典研究理事会;
关键词
Genital herpes; Sexually transmitted infections; Adjuvant; Toll like receptor; Mucosal immunity; Mucosal vaccine; SIMPLEX-VIRUS TYPE-2; CPG OLIGODEOXYNUCLEOTIDES; GAMMA-INTERFERON; T-CELLS; INFECTION; ADJUVANT; DELIVERY; VACCINES; RESPONSES; INNATE;
D O I
10.1016/j.vaccine.2009.11.035
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The purpose of this study was to investigate the potential of intranasal (IN) immunization with Neisseria meningitides B proteoliposome (AFPL1) and AFPL1-derived cochleate (AFCo1), containing glycoprotein D (gD) of herpes simplex virus type 2 (HSV-2) for induction of protective immunity against genital herpes infection in mice. We could show that IN immunization with both AFPL1 and AFCo1 containing gD induced gD-specific IgG antibody and lymphoproliferative responses. However, IFN-gamma response could only be detected in CD4(+) splenic cells and genital lymph node cells of the AFCo1gD immunized mice upon recall antigen stimulation in vitro. Importantly, IN immunization with AFCo1gD could elicit a complete protection against an otherwise lethal vaginal challenge with HSV-2, while the AFPL1gD immunized mice were only partially protected. Further, we could show that the IFN-gamma response and protective immunity observed after IN immunization with AFCo1gD are mediated via the adaptor molecule myeloid differentiation factor 88. These data may have implications for the development of a mucosal vaccine against genital herpes. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1193 / 1200
页数:8
相关论文
共 34 条
[1]   Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa [J].
Abu-Raddad, Laith J. ;
Magaret, Amalia S. ;
Celum, Connie ;
Wald, Anna ;
Longini, Ira M., Jr. ;
Self, Steven G. ;
Corey, Lawrence .
PLOS ONE, 2008, 3 (05)
[2]   Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice [J].
Acevedo, Reinaldo ;
Callico, Adriana ;
del Campo, Judith ;
Gonzalez, Elizabeth ;
Cedre, Barbara ;
Gonzalez, Lissette ;
Romeu, Belkis ;
Zayas, Caridad ;
Lastre, Miriam ;
Fernandez, Sonsire ;
Oliva, Reynaldo ;
Garcia, Luis ;
Luis Perez, Jose ;
Perez, Oliver .
METHODS, 2009, 49 (04) :309-315
[3]   Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA [J].
Ashkar, AA ;
Yao, XD ;
Gill, N ;
Sajic, D ;
Patrick, AJ ;
Rosenthal, KL ;
Rosenthal, L .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (10) :1841-1849
[4]   Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2 [J].
Ashkar, AA ;
Bauer, S ;
Mitchell, WJ ;
Vieira, J ;
Rosenthal, KL .
JOURNAL OF VIROLOGY, 2003, 77 (16) :8948-8956
[5]   B Cell Intrinsic MyD88 Signals Drive IFN-γ Production from T Cells and Control Switching to IgG2c [J].
Barr, Tom A. ;
Brown, Sheila ;
Mastroeni, Pietro ;
Gray, David .
JOURNAL OF IMMUNOLOGY, 2009, 183 (02) :1005-1012
[6]   Herpes simplex virus vaccines [J].
Bernstein, DI ;
Stanberry, LR .
VACCINE, 1999, 17 (13-14) :1681-1689
[7]   Nasal vaccines [J].
Davis, SS .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 51 (1-3) :21-42
[8]   Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses [J].
del Campo, Judith ;
Zayas, Caridad ;
Romeu, Belkis ;
Acevedo, Reinaldo ;
Gonzalez, Elizabeth ;
Bracho, Gustavo ;
Cuello, Maribel ;
Cabrera, Osmir ;
Balboa, Julio ;
Lastre, Miriam .
METHODS, 2009, 49 (04) :301-308
[9]  
DELCAMPO J, 2002, VACCINE S2, V24
[10]  
FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511